Hungary to get Avigan for treatment of Covid-19 patients
Photo by bonilook / Shutterstock.com
The research center of the University of Pécs received 12,200 pieces of Japanese-registered influenza drug Avigan this morning (Saturday, May 23), said Minister of Foreign Affairs and Trade Péter Szijjártó.
Avigan, also known as favipiravir, T-705, or favilavir is an antiviral drug whose early laboratory studies show it is effective in the treatment of coronavirus. Photo by bonilook / Shutterstock.com
In his Facebook video, the minister mentioned that its active ingredient, favipiravir, has been found to be effective against COVID-19. Hungary is one of the 29 countries to receive the medicine from Japan for treatment and further clinical testing.
Professor Gábor L. Kovács, who also participated in the Facebook video, said that Avigan will be used for tests on 100 Hungarian patients “under controlled conditions and with the utmost care.”
MOL Shareholders Approve Dividend of Around HUF 250/Share
Chinese President to Visit Budapest in May
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
